Lead Product(s) : Diquafosol Sodium
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Santen Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 27, 2023
Lead Product(s) : Diquafosol Sodium
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Santen Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable